ATC Group: B02BX12 Fitusiran

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of B02BX12 in the ATC hierarchy

Level Code Title
1 B Blood and blood forming organs
2 B02 Antihemorrhagics
3 B02B Vitamin K and other hemostatics
4 B02BX Other systemic hemostatics
5 B02BX12

Active ingredients in B02BX12

Active Ingredient

Fitusiran is a double-stranded siRNA that causes degradation of AT messenger RNA (mRNA) through RNA interference, reducing plasma AT levels.

Related product monographs

Document Type Information Source  
 QFITLIA Solution for injection MPI, US: SPL/PLR FDA, National Drug Code (US)

United States medicines